Experts has a new look! Let us know what you think of the updates.

Provide feedback

Scholarly Works

Evaluating Cost-Effectiveness: An Essential Part...

Journal article

Evaluating Cost-Effectiveness: An Essential Part of New Cancer Drug Approvals

Authors

Evans WK; de Oliveira C

Journal

Journal of Thoracic Oncology, Vol. 12, No. 10, pp. 1461–1463

Publisher

Elsevier

Publication Date

10 2017

DOI

10.1016/j.jtho.2017.08.013

ISSN

1556-0864

Associated Experts

William Evans

Professor Emeritus, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical sciences 3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

Cost-Benefit Analysis Drug Approval Humans Lung Neoplasms United States Food and Drug Administration

View published work (Non-McMaster Users)

View published work (McMaster Users)